3M’s inventions have improved daily life for hundreds of millions of people all over the world since 1902. Silvia Perez, President and General Manager of the Drug Delivery Systems (DDS) Division of 3M, highlights some of her company’s recent innovations.
What would you say have been the most significant developments in the industry in terms of Drug Delivery over the past 21 years?
The most significant development has been the explosive growth in the number of generic drugs arriving on the market. Generics have created new dynamics across the greater healthcare industry that have impacted everything – from accessibility and affordability for patients and payers, to the business models of pharmaceutical companies and their partners, including 3M DDS.
This webinar showcases the Growth Direct System; an RMM (Rapid Microbial Method) that improves on traditional membrane filtration, delivering increased accuracy, a faster time to result, enhanced data integrity compliance, and more control over the manufacturing process.
Key learning points:
Understand the benefits of full workflow microbiology quality control testing automation in radiopharmaceutical production
Learn about ITM’s implementation journey and considerations when evaluating the technology
Find out how the advanced optics and microcolony detection capabilities of Growth Direct® technology impact time to result (TTR).
Don’t miss your chance to learn from experts in the industry –Register for FREE
Can’t attend live? No worries – register to receive the recording post-event.
Specifically, for 3M DDS, the expiration of drug patents is now putting intense pressure on those original, branded drugs to stay relevant in the marketplace. Meanwhile, the expiration of a patent also puts intense pressure on those companies now competing to bring a generic version of that drug to market. They must all find ways to make their products, which is ultimately the same drug, stand out from the others. Pinpointing new strategies for marketability will continue to be a major challenge for many years to come.
[insert_php] if ( zmember_valid_subscription() ) { echo ‘
DOWNLOAD THE ENTIRE 21st ANNIVERSARY SUPPLEMENT NOW
Our 21 @ 21 Anniversary Supplement is just one of the many resources a free subscription to European Pharmaceutical Review provides. If you are already a subscriber, login to download the PDF.
Not yet a subscriber? Join our growing community of thousands of industry professionals and gain access to:
Bi-monthly issues in print and/or digital format
Case studies, whitepapers, webinars and industry-leading content
Breaking news and features
Our extensive online archive of over 8,500 articles and past issues
At 3M DDS, we know one of the most important ways a drug can stand out from similar formulations is the way in which that drug is delivered to the patient. If one drug delivery method is easier for a patient to use, less painful and more affordable than the competition, one can surmise that patients and providers would favour that product over the rest.
To develop those superior drug delivery methods, in recent years, 3M DDS has begun to invest heavily in research and development. We are pushing ourselves to innovate more than ever before because we know the competition is fierce – and we believe our long history of innovation and invention lends itself to this challenge.
One outcome of that push has been the digitally-driven 3M Intelligent Control Inhaler (3M ICI), for asthma and COPD patients. Research shows that many such patients do not use their inhalers correctly, which leads to poorer health and the higher healthcare costs that come with it. The 3M ICI aims to improve patient outcomes by:
Coaching patients on how to use the inhaler properly
Using detection mechanisms to ensure that they received the correct dose
Recording that data through connectivity to their smartphones and tablets.
Looking ahead to the next few years, what do you think is likely to be the main opportunities and challenges in terms of drug delivery?
Digitisation will continue to present incredible opportunities to improve the delivery of drugs to patients in ways never before thought possible. Through our research and development efforts, we are working every day to identify those opportunities and figure out how to apply digital technology to other drug delivery devices, including transdermal patches and microneedles.
The ultimate opportunity boils down to empowering patients to take more control of their healthcare journey. For instance, if a patient could self-administer a drug at home, rather than making a trip to the doctor’s office, the process would be more cost-effective, time-efficient, and potentially lead to improved adherence – which could lead to better outcomes. Digitisation will drive that opportunity.
The major challenge will continue to be achieving a business model that can withstand the pressures of bringing such opportunities to market. When it comes to generics, in particular, most price margins are thin, which can inhibit the ability to innovate improved drug delivery systems. In this digital age, it would also be understandable for regulators to be cautious of new technology that has never before been used. With no prior data, the process to ensure patient safety must be rigorous and could be potentially slower than we’re accustomed to in the pharmaceutical and drug delivery industries.
How is 3M preparing for these developments?
3M DDS continues to invest heavily in its own research and development. We are hiring more resources with experience in the fields of software, hardware and data analytics. We are growing our talent pool with a focus on connectivity and digitisation. We are also investing in partnerships with start-up tech companies, to help address the challenges of achieving an effective and sustainable business model in this new digital age.
Company profile
3M is a global science company that never stops inventing. Using 46 technology platforms, our integrated team of scientists and researchers works with customers to create breakthroughs. Our inventions have improved daily life for hundreds of millions of people all over the world since 1902. With more than $30bn in sales, our 90,000 employees connect with customers all around the world. Scientists, researchers, and marketers work across countries and across subjects to solve challenges big and small. 3M Drug Delivery Systems (3M DDS) is one such division, which has over 60 years of global pharmaceutical development and manufacturing experience. We provide proven inhalation, transdermal, oral and topical manufacturing expertise – from feasibility to market.
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.